AIM:To investigate the effect of anti-VEGF combined with panretinal photocoagulation(PRP)in the treatment of severe non-proliferative diabetic retinopathy(sNPDR)with diabetic macular edema(DME)on the change of macular blood flow density.METHODS: Data of 30 eyes in 30 patients at Guangxi Zhuang Autonomous Region People's Hospital from October 2018 to April 2019 were retrospectively reviewed, and they were randomly divided into group A and group B each with 15 cases. Group A was received PRP treatment after one initial intravitreal ranibizumab injection followed by pro re nata(PRN)at 7d, while group B was administered PRP alone. The blood flow density of superficial capillary plexus(SCP)and deep capillary plexus(DCP)in macular area(6mm×6mm), ...
AIM:To retrospectively analyze clinical effect of laser therapy combined with or without Ranibizumab...
· AIM: To study plasma levels of vascular endothelial growth factor (VEGF), endothelin-1 (ET-1) and ...
AIM: To discuss the prognosis effects of vascular endothelial growth factor(VEGF)inhibitors combined...
AIM: To observe the effect of panretinal photocoagulation(PRP)combined with anti-vascular endothelia...
AIM: To investigate the influence of laser photocoagulation and vascular endothelial growth factor(V...
AIM: To observe the interaction of Ranibizumab and laser in the treatment of proliferative diabetic ...
AIM: To investigate the effects of fundus laser combined with anti-vascular endothelial growth facto...
Background Diabetic retinopathy is a major cause of sight loss in people with diabetes. The most sev...
AIM:To investigate the clinical efficacy of Ranibizumab combined with laser photocoagulation in the ...
AIM: To evaluate the effect of Conbercept or Aflibercept on macular perfusion status in patients wit...
Purpose: This study investigates the effect of pattern scanning laser (PASCAL) panretinal photocoagu...
AIM: To observe the efficacy and safety of intravitreal injection of anti-vascular endothelial growt...
Diabetic macular edema (DME) is the most common cause of vision loss in diabetic patients. Thirty ye...
Diabetic macular edema is the leading cause of moderate visual deterioration in patients with diabet...
Objective: to analyze the structural state of the central area of the retina in diabetic macular ede...
AIM:To retrospectively analyze clinical effect of laser therapy combined with or without Ranibizumab...
· AIM: To study plasma levels of vascular endothelial growth factor (VEGF), endothelin-1 (ET-1) and ...
AIM: To discuss the prognosis effects of vascular endothelial growth factor(VEGF)inhibitors combined...
AIM: To observe the effect of panretinal photocoagulation(PRP)combined with anti-vascular endothelia...
AIM: To investigate the influence of laser photocoagulation and vascular endothelial growth factor(V...
AIM: To observe the interaction of Ranibizumab and laser in the treatment of proliferative diabetic ...
AIM: To investigate the effects of fundus laser combined with anti-vascular endothelial growth facto...
Background Diabetic retinopathy is a major cause of sight loss in people with diabetes. The most sev...
AIM:To investigate the clinical efficacy of Ranibizumab combined with laser photocoagulation in the ...
AIM: To evaluate the effect of Conbercept or Aflibercept on macular perfusion status in patients wit...
Purpose: This study investigates the effect of pattern scanning laser (PASCAL) panretinal photocoagu...
AIM: To observe the efficacy and safety of intravitreal injection of anti-vascular endothelial growt...
Diabetic macular edema (DME) is the most common cause of vision loss in diabetic patients. Thirty ye...
Diabetic macular edema is the leading cause of moderate visual deterioration in patients with diabet...
Objective: to analyze the structural state of the central area of the retina in diabetic macular ede...
AIM:To retrospectively analyze clinical effect of laser therapy combined with or without Ranibizumab...
· AIM: To study plasma levels of vascular endothelial growth factor (VEGF), endothelin-1 (ET-1) and ...
AIM: To discuss the prognosis effects of vascular endothelial growth factor(VEGF)inhibitors combined...